Investment Opportunity
Funding Roadmap
Structured capital deployment across six rounds, from pre-seed to public markets. A $485 billion market opportunity.
Market Opportunity
$485B
Healthcare AI market by 2030
17.3%
Market CAGR 2024-2030
62%
VC funding goes to AI health
$34.4M
Avg AI health funding round
Funding Rounds
Pre-Seed — Q2 2026
$200–500K
MVP development, founding team, 3 pilot hospitals in Hyderabad, patent filings.
Seed — Q4 2026
$1–2M
Product-market fit, 20 customers, ABDM marketplace launch, team scaling to 15.
Series A — Q2 2027
$5–10M
India scale, US FDA preparation, clinical validation studies, 100 hospitals.
Series B — 2028
$20–40M
US market launch, 200+ hospitals, regional expansion to Southeast Asia.
Series C — 2029-30
$50–100M
Global scale, platform consolidation, IPO preparation, 500+ hospitals.
IPO — 2031-32
$200M+
Dual listing BSE/NSE + NASDAQ. $100M+ ARR. 1,000+ customers globally.
Why Invest in AIXStream?
→First-mover advantage — no full-stack healthcare AI platform exists in India
→5 validated market gaps with zero competition
→$485B TAM growing at 17.3% CAGR
→Platform economics — 6 products, shared infrastructure, compounding value
→India-first strategy with global expansion roadmap
→Founder with 10+ years of AI/ML architecture experience at enterprise scale
→Healthcare AI has the highest VC funding concentration — 62% of all AI deals
→Veeva Systems playbook — they reached $65B market cap with the same platform approach in life sciences